Latest News by Industry
CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Editas Medicine Inc. (EDIT) on Wednesday reported a loss of $67.6 million in its second quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 82 cents.
The results missed Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of 69 cents per share.
The genome editing company posted revenue of $513,000 in the period, which also did not meet Street forecasts. Six analysts surveyed by Zacks expected $6.8 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EDIT at https://www.zacks.com/ap/EDIT